ArticleStroke and vascular neurology2025

IRIS, a randomised, double-blind, placebo-controlled trial of interleukin-6 receptor inhibition undergoing endovascular treatment in acute anterior circulation ischaemic stroke: study rationale and design.

Xuehong Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.